Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Christopher Cromwell, Ph.D.

Concepts (60)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Christopher Cromwell's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Christopher Cromwell has written about over time.
Fluorescence Resonance Energy Transfer, 1 publications between 2018 and 2018, average publication date April 2018. RNA, 1 publications between 2018 and 2018, average publication date April 2018. Streptococcus pyogenes, 1 publications between 2018 and 2018, average publication date April 2018. DNA, 2 publications between 2018 and 2021, average publication date August 2019. DNA Cleavage, 3 publications between 2018 and 2021, average publication date February 2020. Genome, 2 publications between 2021 and 2021, average publication date January 2021. Nicotinamide Phosphoribosyltransferase, 1 publications between 2021 and 2021, average publication date February 2021. Cell Nucleolus, 1 publications between 2021 and 2021, average publication date June 2021. Matrix Metalloproteinase 2, 1 publications between 2021 and 2021, average publication date June 2021. RNA, Ribosomal, 1 publications between 2021 and 2021, average publication date June 2021. Semaphorin-3A, 1 publications between 2022 and 2022, average publication date March 2022. Nerve Tissue Proteins, 2 publications between 2022 and 2022, average publication date May 2022. Phosphoric Monoester Hydrolases, 1 publications between 2022 and 2022, average publication date July 2022.

To see the data from this visualization as text, click here.
Cromwell's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (60)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.